HOIP for targeting diffuse large B-cell lymphoma

Research output: Contribution to journalReview articlepeer-review


In this issue of Blood, Jo et al1 provide compelling evidence in a mouse model that enhanced activity of the linear ubiquitin chain assembly complex (LUBAC) can drive B-cell lymphomagenesis and may offer a new therapeutic target for the activated B-cell–like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL).

Original languageEnglish (US)
Pages (from-to)646-647
Number of pages2
Issue number6
StatePublished - Aug 2020

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'HOIP for targeting diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Cite this